Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Genotyping Analysis Services

U.S. Department Of Defense·Maryland

Genotyping Analysis Services

Closes 8/3/2026$1M – $5MRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The US Army Army Research Institute of Environmental Medicine (USARIEM) requires genotyping analysis services for 648 DNA samples. The selected vendor will be responsible for delivering large-scale, high-density array-based genotyping services. The Illumina Global Diversity Array (GDA) is required to support population genetic analyses, ancestry inference, polygenic score calculation, and genome-wide association studies (GWAS). The vendor must have prior experience processing and analyzing 10,000 samples for the federal government and be a GLP-compliant lab with documented, reviewed, and updated SOPs. • The contract will be for a firm-fixed price. • The period of performance is from 04 Aug 2026 to 03 Aug 2027. • The vendor must submit a unit price and total price for the contract line item. • The government reserves the right to conduct discussions with offerors if necessary.

Attached files

Contact

Nicholas VanDevander(Contracting Officer)

[email protected]

(301) 619-2265

Key dates

Opened
7/8/2026
Questions due
7/16/2026
Closes
8/3/2026
Duration
365 days

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
621511
Solicitation №
HT942626QE044

Budget estimate

$1,000,000 – $5,000,000

The estimated budget for this opportunity is between $1,000,000 and $5,000,000. This estimate is based on the fact that the contract is for genotyping analysis services for 648 DNA samples, and the cost of such services can vary widely depending on the complexity of the analysis and the technology used. The government has specified a firm-fixed price contract, which suggests that the budget will be a fixed amount rather than an hourly or daily rate. The NAICS code for this opportunity is Medical and Diagnostic Laboratories (621511), which suggests that the budget will be in the range of $1,000,000 to $5,000,000.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 65%

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

65% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. Department Of The Interior·United States of America

64% match

Q--MOJAVE TORTOISE BIOINFORMATICS

Closes 10/31/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

64% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. Department Of Health And Human Services·Maryland

64% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

Tarrant County·Texas

64% match

Purchase of Genetic Analysis Instrument and Maintenance

Closes 11/5/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

64% match

Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Closes 1/8/2027Opened 5/14/2025

U.S. National Institutes of Health·United States of America

64% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

U.S. National Institutes of Health·United States of America

63% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

63% match

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 8/13/2024

U.S. National Institutes of Health·United States of America

63% match

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Closes 1/11/2027Opened 1/20/2026

U.S. National Science Foundation·United States of America

63% match

Statistics

Rolling / TBD closeOpened 3/29/2018

U.S. National Institutes of Health·United States of America

63% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

62% match

Limited Competition: The NHGRI Analysis, Visualization, and Informatics Lab-space (AnVIL) (U54 Clinical Trial Not Allowed)

Closes 5/24/2027Opened 6/2/2026

U.S. National Institutes of Health·United States of America

62% match

Research on the Ethical, Legal and Social Implications (ELSI) of Genomics

Closes 2/15/2027Opened 6/3/2026

U.S. National Institutes of Health·United States of America

62% match

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 6/6/2025

Washington Labor & Industries, Department of·Washington

62% match

Biostatistical Support for SHARP Research Program

Closes 12/21/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

62% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

LA County Sheriff·California

62% match

RFSQ - DNA Laboratory Services

Rolling / TBD closeOpened 11/9/2021

U.S. National Institutes of Health·United States of America

62% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

61% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

61% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

61% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

61% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

61% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023